Kenvue Inc. (KVUE)
Listed on NYSE • Consumer Defensive / Household & Personal Products
Overview
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
Explore More Data
Key Information
Symbol:
KVUE
CEO:
Thibaut Mongon
Exchange:
NYSE
CIK:
0001944048
Website:
https://www.kenvue.com
SEC Filings:
View SEC →
Stock Snapshot (Updated: Nov 05 04:00 PM EST)
Price
16.23
Change
0.26
Change %
1.63%
Open
16.01
Previous Close
15.97
High
16.45
Low
15.95
Volume
51,856,727
Market Cap
31,093,467,136
EV/EBITDA
11.07
Capital Structure (Updated: Nov 05 04:00 PM EST)
Shares Outstanding
1,915,802,170
FloatShares
1,912,813,519
Float Ratio
99.84%
Shares Short
29,028,925
Short Percent Of Float
The percent of float shares currently sold short. Reflects market sentiment and risk of a short squeeze.
2.01%
Short Ratio
Days needed to cover all short positions. Indicates short-selling pressure.
0.81 trading days
Held Percent Insiders
0.04%
Held Percent Institutions
101.25%
Calendar Events (Upcoming Earnings & Revenue Forecasts)
| Earnings | |
| Earnings Date | 2025-11-03 |
| Earnings Call | 2025-11-06 |
| Avg EPS Estimate | 0.2314 |
| Low EPS Estimate | 0.2137 |
| High EPS Estimate | 0.2565 |
| Revenue | |
| Avg Revenue Forecast | 3,711,590,300 |
| Low Revenue Forecast | 3,678,585,000 |
| High Revenue Forecast | 3,760,874,000 |
KVUE Liquidity Indicators Shows key metrics that reflect cash availability and short-term payment ability
| Field | Value | Description |
|---|---|---|
| Cash Holdings | $1,139,000,064 | Cash on hand, which directly shows a company's ability to meet short-term obligations. |
| Quick Ratio | 0.577 | The quick ratio, which excludes inventory, measures short-term solvency; a value above 1 is considered relatively safe. |
| Current Ratio | 0.98 | The current ratio, calculated as current assets divided by current liabilities; the higher the value, the better the liquidity. |
| Total Debt | $9,109,000,192 | Total liabilities, used together with cash and liquidity ratios to assess debt burden. |
KVUE Profitability Indicators Shows key metrics that reflect overall earnings, margins, and core business profitability
| Field | Value | Description |
|---|---|---|
| EBITDA | $3,540,999,936 | EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), which measures the profitability of core operations. |
| Operating Cash Flow | $2,136,000,000 | Operating cash flow, which reflects a company's cash-generating ability. |
| Free Cash Flow | $1,753,374,976 | Free cash flow, after deducting capital expenditures, which can be used for dividends or reinvestment. |
| Gross Margin | 58.33% | Gross margin; a higher value indicates stronger product profitability. |
| Operating Margin | 19.29% | Operating margin; slightly negative, indicating high operating costs. |
| Profit Margin | 9.55% | Net profit margin, which reflects overall profitability. |
KVUE Leverage & Financial Health Indicators Shows key metrics that reflect debt levels, liquidity, and overall financial stability
| Field | Value | Description |
|---|---|---|
| Debt/Equity Ratio | 85.66% | Low leverage level, indicating the company has low debt pressure. |
| Total Debt | $9,109,000,192 | Used together with cash and EBITDA to assess debt-paying ability. |
KVUE Growth Indicators Shows key financial metrics that reflect profitability, cash flow, and business expansion
| Field | Value | Description |
|---|---|---|
| Revenue Growth (YoY) | -3.50% | Rapid revenue growth, indicating fast business expansion. |
| Earnings Growth (YoY) | 3.80% | Significant EPS growth, indicating rapid improvement in profitability. |
Financial Data for KVUE (Key ratios, margins, and cash flow)
| Field | Value | Description |
|---|---|---|
| Current Price | $16.23 | Latest stock trading price |
| Price Target (High) | $23 | Analyst highest expected price |
| Price Target (Low) | $17 | Analyst lowest expected price |
| Price Target (Average) | $19.42 | Average target price across analysts |
| Price Target (Median) | $18.5 | Median of target prices |
| Average Rating Score | 2.57 | Average analyst rating (1=Strong Buy, 5=Sell) |
| Consensus Recommendation | hold | Consensus rating |
| Analyst Coverage Count | 12 | Number of analysts providing estimates |
| Cash Holdings | $1,139,000,064 | Total cash held by the company |
| Cash per Share | $0.59 | Cash value per outstanding share |
| Total Debt | $9,109,000,192 | Company's total debt |
| Quick Ratio | 0.577 | Ability to cover short-term liabilities (excludes inventory) |
| Current Ratio | 0.98 | Overall short-term liquidity |
| Debt/Equity Ratio | 85.66% | Leverage ratio: Debt / Equity |
| EBITDA | $3,540,999,936 | Earnings before interest, taxes, depreciation & amortization |
| Total Revenue | $15,006,000,128 | Total company revenue |
| Revenue per Share | $7.83 | Total revenue divided by shares outstanding |
| Gross Profit | 58.33% | Revenue minus cost of goods sold |
| Return on Assets | 6.86% | Net income / Total assets |
| Return on Equity | 13.47% | Net income / Shareholder equity |
| Earnings Growth (YoY) | 3.80% | Year-over-year EPS growth |
| Revenue Growth (YoY) | -3.50% | Year-over-year revenue growth |
| Gross Margin | 58.33% | Gross profit / Total revenue |
| EBITDA Margin | 23.60% | EBITDA / Revenue |
| Operating Margin | 19.29% | Operating income / Revenue |
| Profit Margin | 9.55% | Net income / Revenue |
| Free Cash Flow | $1,753,374,976 | Cash left after capital expenditures |
| Operating Cash Flow | $2,136,000,000 | Cash from core business operations |
| Currency | USD | Reported in US dollars |
| Last Updated | 2025-11-05 | Data source from Yahoo |